OPXAW

Opexa Therapeutics, Inc.
OPXAW

Overview Fund Activity
Delisted

OPXAW was delisted on the 20th of September, 2017.

Back to rankings

4 hedge funds and large institutions have $134K invested in Opexa Therapeutics, Inc. in 2017 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
-2
Holders Change %
-33.33%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
VKH
1
Virtu KCG Holdings
New York
$79K
2
TSS
2
Two Sigma Securities
New York
$20K

Top Sellers

1
Millennium Management
1
Millennium Management
New York
$0
2
Bank of New York Mellon
2
Bank of New York Mellon
New York
$6K
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
VKH
1
Virtu KCG Holdings
New York
$79K +$73.6K +670,753 +1,358%
California Public Employees Retirement System
2
California Public Employees Retirement System
California
$29K – – –
TSS
3
Two Sigma Securities
New York
$20K +$20K +181,400 New
Bank of New York Mellon
4
Bank of New York Mellon
New York
$6K -$6.37K -53,110 -52%
Millennium Management
5
Millennium Management
New York
– -$27K -1,600,000 Closed
Susquehanna International Group
6
Susquehanna International Group
Pennsylvania
– -$4K -256,572 Closed